Bose A, O’Neal WT, Wu C, McClure LA, Judd SE, Howard VJ, Howard G, Soliman EZ. Sex Differences in Risk Factors for Incident Atrial Fibrillation (from the Reasons for Geographic and Racial Differences in Stroke [REGARDS] Study). Am J Cardiol. 2019;123(9):1453–1457. https://doi.org/10.1016/j.amjcard.2019.01.056. PMID: 30771859IF: 2.1 Q3 B3.
Gaudino M, Di Franco A, Rong LQ, Piccini J, Mack M. Postoperative atrial fibrillation: from mechanisms to treatment. Eur Heart J. 2023;44(12):1020–39. https://doi.org/10.1093/eurheartj/ehad019.
Google Scholar
Shin J, Han K, Jung JH, Park HJ, Kim W, Huh Y, Kim YH, Kim DH, Kim SM, Choi YS, Cho KH, Nam GE. Age at menopause and risk of heart failure and atrial fibrillation: a nationwide cohort study. Eur Heart J. 2022;43(40):4148–57. https://doi.org/10.1093/eurheartj/ehac364.
Google Scholar
van de Kar MRD, van Brakel TJ, Van’t Veer M, van Steenbergen GJ, Daeter EJ, Crijns HJGM, van Veghel D, Dekker LRC, Otterspoor LC. Anticoagulation for post-operative atrial fibrillation after isolated coronary artery bypass grafting: a meta-analysis. Eur Heart J. 2024;45(29):2620–2630. https://doi.org/10.1093/eurheartj/ehae267. PMID: 38809189IF: 35.6 Q1 B1.
Matos JD, McIlvaine S, Grau-Sepulveda M, Jawitz OK, Brennan JM, Khabbaz KR, Sellke FW, Yeh R, Zimetbaum P. Anticoagulation and amiodarone for new atrial fibrillation after coronary artery bypass grafting: Prescription patterns and 30-day outcomes in the United States and Canada. J Thorac Cardiovasc Surg. 2021;162(2):616–624.e3. https://doi.org/10.1016/j.jtcvs.2020.01.077. PMID: 32197901IF: 4.4 Q1 B2.
Oraii A, Masoudkabir F, Pashang M, Jalali A, Sadeghian S, Mortazavi SH, Ghorbanpour Landy M, Pourhosseini H, Salarifar M, Mansourian S, Bagheri J, Momtahan S, Karimi A. Effect of postoperative atrial fibrillation on early and mid-term outcomes of coronary artery bypass graft surgery. Eur J Cardiothorac Surg. 2022;62(3): ezac264. https://doi.org/10.1093/ejcts/ezac264.
Google Scholar
Caldonazo T, Kirov H, Rahouma M, Robinson NB, Demetres M, Gaudino M, Doenst T, POAF-MA Group. Atrial fibrillation after cardiac surgery: A systematic review and meta-analysis. J Thorac Cardiovasc Surg. 2023;165(1):94–103.e24. https://doi.org/10.1016/j.jtcvs.2021.03.077. PMID: 33952399IF: 4.4 Q1 B2.
Eikelboom R, Sanjanwala R, Le ML, Yamashita MH, Arora RC. Postoperative atrial fibrillation after cardiac surgery: a systematic review and meta-analysis. Ann Thorac Surg. 2021;111(2):544–54. https://doi.org/10.1016/j.athoracsur.2020.05.104.
Google Scholar
Nelson HD. Menopause. Lancet. 2008;371(9614):760–70. https://doi.org/10.1016/S0140-6736(08)60346-3.
Google Scholar
Mishra SR, Chung HF, Waller M, Dobson AJ, Greenwood DC, Cade JE, Giles GG, Bruinsma F, Simonsen MK, Hardy R, Kuh D, Gold EB, Crawford SL, Derby CA, Matthews KA, Demakakos P, Lee JS, Mizunuma H, Hayashi K, Sievert LL, Brown DE, Sandin S, Weiderpass E, Mishra GD. Association between reproductive life span and incident nonfatal cardiovascular disease: a pooled analysis of individual patient data from 12 studies. JAMA Cardiol. 2020;5(12):1410–8. https://doi.org/10.1001/jamacardio.2020.4105.
Google Scholar
InterLACE Study Team. Variations in reproductive events across life: a pooled analysis of data from 505 147 women across 10 countries. Hum Reprod. 2019;34(5):881–893. https://doi.org/10.1093/humrep/dez015. PMID: 30835788IF: 6.1 Q1 B1.
de Souza Macêdo PR, Rocha TN, Gomes Fernandes SG, Apolinário Vieira MC, Jerez-Roig J. Aires da Câmara SM. Possible association of early menopause with worse physical function: a systematic review. Menopause. 2021;28(4):467–475. doi: 10.1097/GME.0000000000001712IF: 3.0 Q1 B3. PMID: 33399317IF: 3.0 Q1 B3.
Mishra GD, Davies MC, Hillman S, Chung HF, Roy S, Maclaran K, Hickey M. Optimising health after early menopause. Lancet. 2024;403(10430):958–68. https://doi.org/10.1016/S0140-6736(23)02800-3.
Google Scholar
Liu J, Jin X, Chen W, Wang L, Feng Z, Huang J. Early menopause is associated with increased risk of heart failure and atrial fibrillation: a systematic review and meta-analysis. Maturitas. 2023;176: 107784. https://doi.org/10.1016/j.maturitas.2023.107784.
Google Scholar
Zhu D, Chung HF, Dobson AJ, Pandeya N, Giles GG, Bruinsma F, Brunner EJ, Kuh D, Hardy R, Avis NE, Gold EB, Derby CA, Matthews KA, Cade JE, Greenwood DC, Demakakos P, Brown DE, Sievert LL, Anderson D, Hayashi K, Lee JS, Mizunuma H, Tillin T, Simonsen MK, Adami HO, Weiderpass E, Mishra GD. Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data. Lancet Public Health. 2019;4(11):e553-e564. https://doi.org/10.1016/S2468-2667(19)30155-0. PMID: 31588031.
McNamara M, Batur P, DeSapri KT. In the clinic. Perimenopause. Ann Intern Med. 2015;162(3):ITC1-15. https://doi.org/10.7326/AITC201502030. PMID: 25643316.
Nashef SA, Roques F, Sharples LD, Nilsson J, Smith C, Goldstone AR, Lockowandt U. EuroSCORE II. Eur J Cardiothorac Surg. 2012;41(4):734 – 44; discussion 744-5. https://doi.org/10.1093/ejcts/ezs043. PMID: 22378855.
Ad N, Holmes SD, Patel J, Pritchard G, Shuman DJ, Halpin L. Comparison of EuroSCORE II, original EuroSCORE, and the Society of Thoracic Surgeons risk score in cardiac surgery patients. Ann Thorac Surg. 2016;102(2):573–9. https://doi.org/10.1016/j.athoracsur.2016.01.105.
Google Scholar
Sun LY, Chu A, Tam DY, Wang X, Fang J, Austin PC, Feindel CM, Oakes GH, Alexopoulos V, Tusevljak N, Ouzounian M, Lee DS, CorHealth Ontario Cardiac Surgery Risk Adjustment Task Group. Derivation and validation of predictive indices for 30-day mortality after coronary and valvular surgery in Ontario, Canada. CMAJ. 2021;193(46):E1757-E1765. https://doi.org/10.1503/cmaj.202901. PMID: 34810162.
Seo EJ, Hong J, Lee HJ, Son YJ. Perioperative risk factors for new-onset postoperative atrial fibrillation after coronary artery bypass grafting: a systematic review. BMC Cardiovasc Disord. 2021;21(1): 418. https://doi.org/10.1186/s12872-021-02224-x.
Google Scholar
Son YJ, Choi HJ, Shim J. Association between postoperative atrial fibrillation after coronary artery bypass grafting and short-term clinical outcomes. BMC Cardiovasc Disord. 2024;24(1): 578. https://doi.org/10.1186/s12872-024-04247-6.
Google Scholar
SenthilKumar G, Katunaric B, Bordas-Murphy H, Sarvaideo J, Freed JK. Estrogen and the vascular endothelium: the unanswered questions. Endocrinology. 2023;164(6): bqad079. https://doi.org/10.1210/endocr/bqad079.
Google Scholar
Iorga A, Cunningham CM, Moazeni S, Ruffenach G, Umar S, Eghbali M. The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy. Biol Sex Differ. 2017;8(1): 33. https://doi.org/10.1186/s13293-017-0152-8.
Google Scholar
Pant A, Gibson AA, Marschner S, Liao LP, Laranjo L, Chow CK, Zaman S. Age of menopause, healthy lifestyle and cardiovascular disease in women: a prospective cohort study. Heart. 2025;111(6):262–8. https://doi.org/10.1136/heartjnl-2024-324602.
Google Scholar
Liu J, Jin X, Liu W, Chen W, Wang L, Feng Z, Huang J. The risk of long-term cardiometabolic disease in women with premature or early menopause: a systematic review and meta-analysis. Front Cardiovasc Med. 2023;10: 1131251. https://doi.org/10.3389/fcvm.2023.1131251.
Google Scholar
de Kleijn MJ, van der Schouw YT, van der Graaf Y. Reproductive history and cardiovascular disease risk in postmenopausal women: a review of the literature. Maturitas. 1999;33(1):7–36. https://doi.org/10.1016/s0378-5122(99)00038-9. PMID: 10585171.
Connelly PJ, Casey H, Montezano AC, Touyz RM, Delles C. Sex steroids receptors, hypertension, and vascular ageing. J Hum Hypertens. 2022;36(2):120–5. https://doi.org/10.1038/s41371-021-00576-7.
Google Scholar
Kheradkhah G, Sheibani M, Kianfar T, Toreyhi Z, Azizi Y. A comprehensive review on the effects of sex hormones on chemotherapy-induced cardiotoxicity: are they lucrative or unprofitable? Cardio-Oncol. 2024;10(1): 86. https://doi.org/10.1186/s40959-024-00293-3.
Google Scholar
Odening KE, Choi BR, Liu GX, Hartmann K, Ziv O, Chaves L, Schofield L, Centracchio J, Zehender M, Peng X, Brunner M, Koren G. Estradiol promotes sudden cardiac death in transgenic long QT type 2 rabbits while progesterone is protective. Heart Rhythm. 2012;9(5):823–32. https://doi.org/10.1016/j.hrthm.2012.01.009.
Google Scholar
Brundel BJJM, Ai X, Hills MT, Kuipers MF, Lip GYH, de Groot NMS. Atrial fibrillation. Nat Rev Dis Primers. 2022;8(1): 21. https://doi.org/10.1038/s41572-022-00347-9.
Google Scholar
Dobrev D, Aguilar M, Heijman J, Guichard JB, Nattel S. Postoperative atrial fibrillation: mechanisms, manifestations and management. Nat Rev Cardiol. 2019;16(7):417–36. https://doi.org/10.1038/s41569-019-0166-5.
Google Scholar
Huang J, Wu B, Qin P, Cheng Y, Zhang Z, Chen Y. Research on atrial fibrillation mechanisms and prediction of therapeutic prospects: focus on the autonomic nervous system upstream pathways. Front Cardiovasc Med. 2023;10: 1270452. https://doi.org/10.3389/fcvm.2023.1270452.
Google Scholar
Imazio M, Brucato A, Ferrazzi P, Rovere ME, Gandino A, Cemin R, Ferrua S, Belli R, Maestroni S, Simon C, Zingarelli E, Barosi A, Sansone F, Patrini D, Vitali E, Trinchero R, Spodick DH, Adler Y, COPPS Investigators. Colchicine reduces postoperative atrial fibrillation: results of the Colchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS) atrial fibrillation substudy. Circulation. 2011;124(21):2290–5. https://doi.org/10.1161/CIRCULATIONAHA.111.026153.
Google Scholar